NanoMuG s.r.l.
About
We harness nature’s defense mechanisms to create a drug delivery platform built on glycosylated mucin nanoparticles. Our technology optimizes targeting and mucoadhesion, reshaping pharmaceutical development and therapeutic outcomes.
To become the strategic partner of choice in the pharmaceutical field, offering innovative, high-impact solutions for oncology, infectious diseases, and mucosal health applications. We are committed to relentless innovation that transforms healthcare and improves patients’ lives.
Life Science Domain
PharmaResearchHealthcare
Research
Academic spin-offs & start-ups
Pharma
Biologics & biosimilarsVaccines & immunology
Medtech
Ophthalmic devices
Representatives
CEO - Nanomug & postdoc researcher
NanoMuG s.r.l.